Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Serge Leyvraz

Showing results (1-10 of 94) with videos related to

Pageof 10
Sort By:
Current Opinion in Oncology|January 12, 2012
Ocular melanoma: what's new?Serge Leyvraz, Ulrich Keilholz
Swiss Medical Weekly|February 24, 2009
Current standards and progress in understanding and treatment of GISTStephan Dirnhofer, Serge Leyvraz
Oncotargets and Therapy|July 10, 2010
Role of trabectedin in the treatment of soft tissue sarcomaAlexandre Christinat, Serge Leyvraz
Revue Medicale Suisse|July 5, 2005
[Dangerous liaisons: relation between oncologist and general practitioner]Jean Bauer, Serge Leyvraz
Revue Medicale Suisse|July 5, 2005
[Can independent clinical research survive?]Matti S Aapro, Serge Leyvraz
Breast (Edinburgh, Scotland)|March 15, 2011
Breast sarcomas: current and future perspectivesIoannis A Voutsadakis, Khalil Zaman, Serge Leyvraz
Revue Medicale Suisse|June 28, 2012
[Not available, cope with it: an unacceptable scandal]Matti Aapro, Pierre-Yves Dietrich, Serge Leyvraz
Revue Medicale Suisse|June 14, 2013
[Late is usually too late, but too much is too much]Matti Aapro, Pierre-Yves Dietrich, Serge Leyvraz
Revue Medicale Suisse|July 12, 2008
[Oncogeriatrics: essential partner in postgraduate education]Matti S Aapro, Serge Leyvraz, André-Pascal Sappino
Revue Medicale Suisse|June 23, 2010
[Medical oncology: the Renaissance revisited...]Matti S Aapro, Serge Leyvraz, André-Pascal Sappino
Pageof 10

Showing results (1-10 of 94) with videos related to

Sort By:
Pageof 10
Current Opinion in Oncology|January 12, 2012
Ocular melanoma: what's new?Serge Leyvraz, Ulrich Keilholz
Swiss Medical Weekly|February 24, 2009
Current standards and progress in understanding and treatment of GISTStephan Dirnhofer, Serge Leyvraz
Oncotargets and Therapy|July 10, 2010
Role of trabectedin in the treatment of soft tissue sarcomaAlexandre Christinat, Serge Leyvraz
Revue Medicale Suisse|July 5, 2005
[Dangerous liaisons: relation between oncologist and general practitioner]Jean Bauer, Serge Leyvraz
Revue Medicale Suisse|July 5, 2005
[Can independent clinical research survive?]Matti S Aapro, Serge Leyvraz
Breast (Edinburgh, Scotland)|March 15, 2011
Breast sarcomas: current and future perspectivesIoannis A Voutsadakis, Khalil Zaman, Serge Leyvraz
Revue Medicale Suisse|June 28, 2012
[Not available, cope with it: an unacceptable scandal]Matti Aapro, Pierre-Yves Dietrich, Serge Leyvraz
Revue Medicale Suisse|June 14, 2013
[Late is usually too late, but too much is too much]Matti Aapro, Pierre-Yves Dietrich, Serge Leyvraz
Revue Medicale Suisse|July 12, 2008
[Oncogeriatrics: essential partner in postgraduate education]Matti S Aapro, Serge Leyvraz, André-Pascal Sappino
Revue Medicale Suisse|June 23, 2010
[Medical oncology: the Renaissance revisited...]Matti S Aapro, Serge Leyvraz, André-Pascal Sappino
Pageof 10